Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8243795 | International Journal of Radiation Oncology*Biology*Physics | 2006 | 8 Pages |
Abstract
Conclusion: Immunoadjuvant OM-174 is an efficient radiosensitizer of tumor cells through activation of the IFN-γ secretion pathway in immune cells. This finding indicates a rationale for combining immunostimulatory and radiosensitizing strategies and extends the potential therapeutic applications of OM-174.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Mark M.D., Ph.D., Valeri N. Ph.D., Carlo Ph.D., Dirk L. M.D., Christinne Monsaert, Kalun Law, Guy A. M.D., Ph.D.,